| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs10846569 |
chr12:124374716-124374717 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 2 |
rs78749219 |
chr12:124374725-124374726 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs188888641 |
chr12:124374731-124374732 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs149868900 |
chr12:124374816-124374817 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs544884345 |
chr12:124374892-124374893 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 6 |
rs181429678 |
chr12:124374943-124374944 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs530607311 |
chr12:124374970-124374971 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs61953571 |
chr12:124374985-124374986 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs75873061 |
chr12:124374987-124374988 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 10 |
rs185868578 |
chr12:124374997-124374998 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs370409370 |
chr12:124374998-124374999 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs555140088 |
chr12:124374999-124375000 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs201416327 |
chr12:124375004-124375005 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs116580147 |
chr12:124375103-124375104 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs35881694 |
chr12:124375117-124375118 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs571245964 |
chr12:124375159-124375160 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs532171926 |
chr12:124375165-124375166 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs572490490 |
chr12:124375166-124375167 |
Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs386767212 |
chr12:124375208-124375209 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs10773046 |
chr12:124375210-124375211 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundancedisease
|
| 21 |
rs536548427 |
chr12:124375251-124375252 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs555117691 |
chr12:124375255-124375256 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs566969573 |
chr12:124375264-124375265 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs377561868 |
chr12:124375294-124375295 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs558657128 |
chr12:124375314-124375315 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs576826824 |
chr12:124375336-124375337 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs145672017 |
chr12:124375341-124375342 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs113574232 |
chr12:124375353-124375354 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs34721462 |
chr12:124375357-124375358 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs370787119 |
chr12:124375400-124375401 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs10846570 |
chr12:124375466-124375467 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 32 |
rs530756106 |
chr12:124375468-124375469 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs542577198 |
chr12:124375508-124375509 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs561101396 |
chr12:124375537-124375538 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs528307662 |
chr12:124375538-124375539 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs540307512 |
chr12:124375562-124375563 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs565018840 |
chr12:124375597-124375598 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs532135026 |
chr12:124375649-124375650 |
Bivalent/Poised TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs189157353 |
chr12:124375694-124375695 |
Bivalent/Poised TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs74560309 |
chr12:124375725-124375726 |
Bivalent/Poised TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs530386303 |
chr12:124375738-124375739 |
Bivalent/Poised TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs79793452 |
chr12:124375742-124375743 |
Bivalent/Poised TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs118071000 |
chr12:124375745-124375746 |
Bivalent/Poised TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs111277240 |
chr12:124375767-124375768 |
Bivalent/Poised TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs533370454 |
chr12:124375778-124375779 |
Bivalent/Poised TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs141918916 |
chr12:124375807-124375808 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs568599595 |
chr12:124375820-124375821 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs150668726 |
chr12:124375836-124375837 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs182554189 |
chr12:124375837-124375838 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs116278391 |
chr12:124375920-124375921 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|